NCT01991977 - 18F-DOPA-PET in Finding Tumors in Patients With Newly Diagnosed Gliomas Undergoing Radiation Therapy | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

July 1, 2019

Study Completion Date

July 15, 2024

Conditions

Malignant Glioma

Interventions

PROCEDURE

Diffusion Weighted Imaging

Undergo DTI

DRUG

Fluorine F 18 Fluorodopa

Undergo 18F-DOPA-PET

RADIATION

Intensity-Modulated Radiation Therapy

Undergo IMRT

PROCEDURE

Perfusion Magnetic Resonance Imaging

Undergo pMRI

PROCEDURE

Positron Emission Tomography

Undergo 18F-DOPA-PET

OTHER

Quality-of-Life Assessment

Ancillary studies

DRUG

Temozolomide

Receive temozolomide

Trial Locations (1)

Mayo Clinic in Rochester, Rochester